ISLA-101 Phase 2a/b PROTECT Clinical Trial Progress Update
Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress on...
Latest Post
Spodumene Pegmatite Discovery at Esperança Project in Brazil Yields LIBS Results up to 4.04% Li2O
Lightning Minerals (L1M or the Company) is delighted to announce the discovery of spodumene within a lithium bearing pegmatite at...
Notice of Initial Substantial Holder – Regal Funds Management Pty Ltd
Provaris Energy Ltd (ASX.PV1, Provaris, the Company) is pleased to present the notice of initial substantial holder. Click here for...
Don’t Miss These Breakouts Poised to Trade Higher!
In this StockCharts TV video, Mary Ellen reveals what took place last week and how the markets closed. She also revealed...
3 Breakouts Ready for Massive Climbs!
As the secular bull market takes a short-term pause, now is the time to research tremendous opportunities that lie ahead....
GM lays off 1,000 employees amid reorganization and cost-cutting
DETROIT — General Motors laid off roughly 1,000 employees on Friday as the automaker attempts to cut costs and realign priorities amid...
Week Ahead: NIFTY May See Mild Rebounds; Painful Mean Reversion May Continue
The Indian benchmark Nifty 50 extended its corrective decline. Over the past four sessions of a truncated week, the Nifty...
Spotting a Bullish Opportunity in Zscaler (ZS) with OptionsPlay Strategy Center
As the cybersecurity landscape continues to evolve with increasing digital threats, Zscaler, Inc. (ZS) stands out as a new opportunity...
Are the Magnificent 7 Still the Kings of Wall Street?
There’s no denying the strength that the mega-cap growth names have exerted on the equity markets in 2024. With their outsized...
Biotechs Fall Apart with Dark Cross Neutral Signal
(This is an excerpt from the subscriber-only DP Weekly Wrap for Friday) On Friday, the Biotechnology ETF (IBB) 20-day EMA...
